...
首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Rationale employment of cell culture versus conventional techniques in pharmaceutical appraisal of nanocarriers
【24h】

Rationale employment of cell culture versus conventional techniques in pharmaceutical appraisal of nanocarriers

机译:与传统技术相比,在纳米载体的药物评估中合理运用细胞培养

获取原文
获取原文并翻译 | 示例
           

摘要

Nanomedicines are enjoying a widespread popularity realizing their intriguing potential to solve drug delivery obstacles. Assessment of major quality attributes of nanocarriers is a crucial process for approving their therapeutic outcomes. Disparate assessment methods that recently encompassed cell line technique were employed. Routinely, a cell line modelwas viewed as an excellent platform for gene and vaccine deliveries. However, its application in pharmaceutical assessment of nanocarriers was not so far overviewed. This review provides a meticulous look at cell culture implementations in evaluation of major quality attributes of nanocarriers, including oral permeability, cytotoxicity and efficiency of tumor targeting. Among others, cell culture technique strikes the right balance between predictability and throughput. It could circumvent drawbacks of in-vivo and in-vitro techniques while gathering privileges of both. Imperative pharmaceutical considerations demanded for proper application of this technique were emphasized. Furthermore, challenges encountered in assessment of versatile nanocarriers were highlighted with proposed solutions. Finally, future research perspectives in this theme issue were suggested.
机译:纳米药物因其解决药物输送障碍的潜在潜力而受到广泛欢迎。评估纳米载体的主要质量属性是批准其治疗结果的关键过程。使用了最近涵盖细胞系技术的不同评估方法。通常,细胞系模型被视为基因和疫苗输送的绝佳平台。然而,到目前为止,其在纳米载体的药物评估中的应用尚未概述。这篇综述详细评估了纳米载体的主要质量属性,包括口服通透性,细胞毒性和肿瘤靶向效率,从而深入研究了细胞培养方法。细胞培养技术尤其在可预测性和通量之间取得了适当的平衡。它可以避开体内和体外技术的弊端,同时获得两者的特权。强调了正确使用此技术所需的必要的药学考虑。此外,提出的解决方案突出了在评估通用纳米载体时遇到的挑战。最后,提出了该主题问题的未来研究观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号